Background: Diabetes mellitus is a pathological condition whose worldwide prevalence is growing, particularly in Africa, contrasting with an inadequacy of screening and diagnosis. This study aimed to evaluate the prevalence of this ailment in an urban environment of Burkina-Faso, as well as the prevalence of cardiovascular comorbid risk factors, such as arterial hypertension and obesity. Patients and methods: We conducted a descriptive cross-sectional study based on the compilation of clinical and biological data randomly collected from participants to a diabetes screening day organized at Ouagadougou (Burkina-Faso) in December 2012. Participants aged <25 years were excluded. The evaluated parameters were age, gender, waist circumference, body mass index, blood pressure, and random (non) fasting capillary plasma glucose measurement, and presence of a metabolic syndrome. Results: There were overall one hundred and sixty five participants: 107 women and 58 men (sex ratio F/H = 1.84). The mean age (±1 SD) of participants was 42.81 ± 11.7 years. The prevalence of screened diabetes was 7.27%, with a prevalence of undiagnosed diabetes of 4.97%. The prevalence of arterial hypertension was 34.55%. The prevalence of obesity was 15.15% (obesity class 1), 5.45% (obesity class 2) and 1.21% (obesity class 3). About 27% of women were obese versus 19.44% of men (p = 0.01). The prevalence of metabolic syndrome was 6.06%, and its presence was significantly associated with the female gender (9.35% in women vs 0% in men, p = 0.005). 50% of subjects screened with diabetes also had a metabolic syndrome versus 2.61% in non-diabetic subjects (p < 0.01). Conclusion: (Un)diagnosed diabetes was highly-prevalent in this urban environment of Burkina Faso undergoing the nutritional transition phase currently prevailing in sub-Saharan Africa. Its presence was significantly co-morbid with the metabolic syndrome, as well as with other major cardiovascular risk factors such as arterial hypertension and obesity.
Introduction
Type 2 diabetes mellitus (T2DM) is a common medical condition characterized by chronic hyperglycemia due to a multifactorial disorder of glucose metabolism and relentless β-cell failure. The prevalence of T2DM is increasing worldwide, and represents a major noncommunicable public health problem. The International Diabetes Federation (IDF) estimated in 2011 that the number of diabetics will increase from 360 million to 550 million in 2030. Furthermore, according to global statistics, the prevalence of diabetes in sub-Saharan Africa may reach 23.9 million in 2030 (vs. 14 million in 2011) [1] . This increase could lead to substantial rises in terms of medical complications as well as in adverse socio-economic impact [2] . The predicted epidemics is all the more worrying since about three-quarters of diabetics in developing countries with low economic level are undiagnosed [3] , due to inadequate screening and prevention programs and low affordability of bioassays for screening and diagnosis. In parallel to the diabetes epicemics, there is also a rapid rise in prevalence of the hypertension and obesity, two comorbidities which contribute to increased cardiovascular morbidity and mortality.
The aim of the present survey was to evaluate the prevalence of (un)diagnosed diabetes and major cardiovascular risk factors such as hypertension and obesity in the urban population of Ouagadougou in Burkina Faso. This pilot survey was carried out during a screening day, and aimed at providing data on prevalence that could be used as proxi for unavailable local data from population-based study on these pathologies.
Patients and Methods
The diabetes screening team conducted a descriptive cross-sectional survey on December 15th, 2012. The study population consisted of the inhabitants of district number 6 of Ouagadougou whose age was ≥25 years. The population of this district number was 317,154 based on the 2006 General Census [4] , and about 63% of these individuals were 15 years-old or more. Participants consisted of volunteers who responded to the screening invitation (relayed through posters and/or town-criers) to participate to a screening day and gave their consent. Each recruited subject was eligible to a review by the medical staff, which consisted of the collection of information on age, gender, occupation, medical history of diabetes and of high blood pressure (hypertension); a clinical assessment consisting of a height measurement (in centimeters), a waist circumference measurement (midway between the iliac crest and the lower edge of the rib cage) with a tape graduated in centimeters, a body weight measurement (in kg using adult EKS ® brand scales), a recording of humeral blood pressure (BP), in the sitting position after five minutes of rest (automatic sphygmomanometer MAGNIEN HL888A SAS ® ); a biological evaluation by measuring casual capillary blood glucose (CCBG, mg/dl) from a drop of digital blood (using a test strip), followed by testing with a glucose sensor (ARKRAY ® Glucocard X-mini plus GT-1960). Calculation of body mass index (BMI = weight/height 2 ) of each participant was used to assess weight status according to the following criteria: BMI < 18. The threshold set for diabetes screening by random capillary plasma glucose (RCPG) was ≥140 mg/dl. Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg, according to the criteria defined by the World Health Organization.
The NCEP-ATP III criteria were used to define the metabolic syndrome (MS) in this population, defining abnormal waist as >102 cm (men) and >88 cm (women), elevated BP as SBP >130 mmHg and/or DBP >85 mmHg; and dysglycemia/diabetes as glucose >110 mg/dl.
The data collected on a single collection sheet were computed using Microsoft Office Excel 2007 software. The analysis was performed using Epi Info 7. The significance level for p < 0.05 was used for statistical tests.
Results
There was a total of 165 participants, whose average age (±1 SD) was 42.81 ± 11.7 years (min-max 25 -75 years), with a sex ratio of 1.84 in favor of women. Patients aged ≥40 years accounted for 55.76% of the study population.
Average random blood glucose measurement was 96.24 ± 33.78 mg/dl [58 -348 mg/dl] ( Table 1) . The overall prevalence of (un)diagnosed diabetes was 7.27% (12/165 subjects, CI = [3.81% -12.36%]) regarding the established criteria ( Table 1 ). The prevalence of diabetes was 7.61% among those aged 40 years or more, and 6.85% in subjects <40 years (p = 0.18). 8.62% of men were diabetic vs. 6.54% of women (p = 0.43). Among diabetic subjects, 4 had a history of known diabetes. As a result, the prevalence of unknown diabetes was 4.97% (8/161 subjects; CI = [2.17% -9.56%]).
Hypertension prevalence was 34.55% (CI = [27.33% -42.33%]) with a mean SBP of 125.31 ± 22.61 mmHg, and a mean DBP of 78.89 ± 12.80 mmHg ( Table 1) . A third of those diagnosed with elevated BP had a known history of hypertension (19/57 subjects), resulting in a 23.03% prevalence of undiagnosed hypertension. Half of the diabetic subjects were hypertensive vs. 33.33% of non-diabetic subjects, although such difference did not reach significance level.
Obesity was also frequent in this population, with a prevalence of 15.15% for Class I obesity, 5.45% for Class II obesity and 1.21% for Class III obesity. Approximately 27% of women were obese against 19.44% of men (p = 0.01). There was no significant difference in the prevalence of obesity in diabetic and non-diabetic subjects (8.33% vs. 22.88%, p = 0.4).
A metabolic syndrome was found in 10 subjects (all women), representing a prevalence of 6.06% in the whole population (CI = [2.94% -10.86%]). The gender imbalance of MS prevalence was highly significant in this population (9.35% of women and 0% of men; p = 0.005). 50% of patients diagnosed with diabetes had a MS vs. 2.61% of non-diabetic subjects (p < 0.01).
Discussion
Screening for diabetes mellitus in urban population by measuring random capillary plasma glucose represents an alternative to the measurement of venous plasma glucose (fasting or OGTT) because it is easier to perform, less expensive and less invasive although results obtained by this method are likely to be influenced by the level of sensitivity and specificity of the material used [5] . The threshold for such screening at 140 mg/dl with the method of RCPG that we used in this study can be considered as the one giving the highest level of sensitivity and specificity for the screening of diabetes mellitus [6] . The fact that it was not feasible to perform confirmatory measurement of fasting plasma glucose in patients diagnosed with diabetes-range hyperglycaemia to fully meet the diagnostic criteria for diabetes is a limitation of this pilot survey, as is the sample size of individuals who participated to the screening. Given the total population of district 6, the present prevalence figures represent useful approximations in need of confirmation, with inherent estimation bias.
The overall prevalence of diabetes recorded in this survey was 7.27%. Compared with prevalence data from the sub-region, we found that our figures are greater than the 3.3% prevalence reported in 2009 by Djorolo et al. from Cotonou [7] , while closer to the 7.7% prevalence recorded in urban areas by Balde et al. in Guinea in 2007 [8] , and the 7.6% prevalence observed in the African subgroup of the Interheart study in 2005 [9] . However, it is significantly lower than the 17.9% prevalence observed in Dakar by Duboz [10] in 2012. Our estimation may be somewhat biased by the participants motivation and characteristics to undergo volunteer screening. Nevertheless, it seems likely that diabetes prevalence is on the increase in urban areas of sub-Saharan Africa compared to the much lower previous 1.1% prevalence recorded in Dakar in 1960 by Payet et al. [11] .
We found a worryingly-high proportion of undiagnosed diabetes among the volunteers screened with hyperglycaemia (8/12 or 66.66%). This proportion is higher than that reported by Balde et al. from Guinea in 2007 from urban areas (59%) [8] , suggesting a major unmet need of screening for diabetes and other cardiometabolic states in urban areas of Burkina-Faso.
The significant association between the presence of diabetes mellitus and the presence of metabolic syndrome in this survey was not unexpected, as most cases of diabetes represent the common form of T2DM, itself strongly comorbid to the MS, through acquired insulin resistance/hyperinsulinaemia and central obesity [12] . It is increasingly recognized that such association, increasingly common, is largely driven by the epidemics of obesity related to changes in human lifestyle over the past few decades (including changes in caloric intake and composition, food security, sedentarity, and decreased work/leisure-time physical activity) particularly in industrialized countries. The same trend is observed today in developing countries, especially in urban environments [13] [14] . However, we did not observe any significant association between the presence of obesity (by BMI or by waist circumference) and the diabetes prevalence in this survey, in line with the observations of ZABSONRE et al. who found no significant associations between obesity and diabetes in Burkina-Faso in 2000 [15] .
Obesity was significantly more frequent among female subjects who participated in this survey (27.1%), slightly less than the 33% figure observed in 2010 by Nono et al. in adult women from Cameroon [16] . More than 60% of obese subjects were women in the studies of Ndiaye-Badiane et al. [17] . The high prevalence of obesity among urban women in sub-Saharan Africa is often ascribed to changes in lifestyles, and also related to adverse socio-cultural factors such as lack of awareness of cardiometabolic risk factors due to low level of education, but also to the culturally-positive perception of many women (and men) that overweight and obesity are linked to favourable socio-economic status.
Hypertension (HBP) was also common in this study (34.55%) but no significant association was found between hypertension and prevalent diabetes. The prevalence of hypertension in this survey was lower than the 40.2% figure found by Niakara et al. in Ouagadougou in 2007 [18] . However, there seems to exist a marked increase in hypertension prevalence in Ouagadougou, based on observations made in 2003 by Niakara et al. of a 23% HBP prevalence in this town [19] . Such a rising trend is likely related as well to changes in lifestyles within the overall framework of growing urbanization and sedentarity.
Conclusion
The present survey confirms that diabetes in urban areas is surging in developing countries such as BurkinaFaso, especially in urban environments which are increasingly considered as diabetogenic. Diabetes prevalence is significantly associated with that of the metabolic syndrome, as well as with a high prevalence of major cardiovascular risk factors such as hypertension and in obesity, in the setting of the nutrition transition prevailing in sub-Saharan Africa. The rapid growth in diabetes mellitus prevalence and cardiovascular risk factors in developing countries, and in sub-Saharan Africa in particular, represents a growing challenge for individuals, communities, health care providers and for all medical, political and economical players. There is an urgent and unmet need, in addition to strengthening prevention programs, for a more thorough evaluation of the current epidemics on a local scale, to better plan and implement interventions, in terms of training of skilled health workers, infrastructures and acquisition of medicines and equipments for proper care of patients to achieve optimal control of this preventable public health problem.
